Certified by Founder Lodge
Orakl Oncology
France - Paris, Île-de-France
START UP
1 Disclosed Funding Rounds $3,147,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Orakl leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncolog
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 04 ,2023 | Unknown | $3,147,000 | |
| December, 03 ,2024 | Seed | $11,563,970 |
Speedinvest
HCVC
Verve Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
